Robert J Adelman's Net Worth
$458 Million
Who is Robert J Adelman?
Robert J Adelman has an estimated net worth of $458 Million. This is based on reported shares across multiple companies, which include Volcano Corp, Checkmate Pharmaceuticals, Inc., ARYx Therapeutics, Inc., RayzeBio, Inc., CRYOCOR INC, Ventyx Biosciences, Inc., ALX ONCOLOGY HOLDINGS INC, Akero Therapeutics, Inc., Metacrine, Inc., IMPEL NEUROPHARMA INC, Elevation Oncology, Inc., and PRECISION BIOSCIENCES INC.
SEC CIK
Robert J Adelman's CIK is 0001329161
Past Insider Trading and Trends
2020 was Robert J Adelman's most active year for acquiring shares with 9 total transactions. Robert J Adelman's most active month to acquire stocks was the month of May. 2020 was Robert J Adelman's most active year for disposing of shares, totalling 35 transactions. Robert J Adelman's most active month to dispose stocks was the month of March. 2020 saw Robert J Adelman paying a total of $22,197,000.00 for 14,705,641 shares, this is the most they've acquired in one year. In 2020 Robert J Adelman cashed out on 35,754,223 shares for a total of $20,743,395.94, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Checkmate Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.75% | -131.65K |
$10.45 | -$1,375,564.42 | 2.16M |
May 13 - May 16
| |||
Form 4
| -6.57% | -160.90K |
$10.39 | -$1,671,823.84 | 2.29M |
May 10 - May 12
| |||
Form 4
| -3.42% | -86.68K |
$10.37 | -$898,920.56 | 2.45M |
May 5 - May 9
| |||
Form 4
| -9.65% | -270.68K |
$10.38 | -$2,809,332.35 | 2.54M |
May 2 - May 4
| |||
Form 4
| -6.34% | -190.03K |
$10.38 | -$1,972,578.78 | 2.81M |
Apr 27 - Apr 29
| |||
Form 4
| -4.15% | -129.78K |
$10.39 | -$1,347,796.50 | 3M |
Apr 22 - Apr 26
| |||
Form 4
| -14.91% | -547.73K |
$10.41 | -$5,700,491.17 | 3.13M |
Apr 19 - Apr 21
| |||
Form 4
|
∞
| 3.67M |
$15.00 |
—
| 3.67M |
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RayzeBio, Inc. (RYZB) Snapshot price: $62.125
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.16M |
—
|
—
| 5.16M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 4M |
$16.00 |
—
| 4M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akero Therapeutics, Inc. (AKRO) Snapshot price: $17.535
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.70% | -116.47K |
$34.40 | -$4,006,536.85 | 3.03M |
Jul 1 - Jul 6
| |||
Form 4
| -1.44% | -45.95K |
$23.76 | -$1,091,607.66 | 3.15M |
Mar 4 - Mar 6
| |||
Form 4
| -0.68% | -21.80K |
$22.63 | -$493,310.23 | 3.2M |
Feb 28 - Mar 3
| |||
Form 4
| -0.18% | -5.90K |
$22.80 | -$134,635.10 | 3.23M |
Feb 25 - Feb 27
| |||
Form 4
| -0.15% | -10.03K |
$27.07 | -$271,399.19 | 6.46M |
Feb 10 - Feb 12
| |||
Form 4
| -0.19% | -6.10K |
$27.03 | -$164,954.76 | 3.23M |
Feb 6
| |||
Form 4
| -2.48% | -82.34K |
$25.77 | -$2,121,726.32 | 3.24M |
Feb 4 - Feb 5
| |||
Form 4
| -12.95% | -494.00K |
$20.23 | -$9,993,620.00 | 3.32M |
Jan 13
| |||
Form 4
| -0.41% | -15.68K |
$19.86 | -$311,354.63 | 3.82M |
Jan 8
| |||
Form 4
| -1.88% | -73.22K |
$19.86 | -$1,454,529.98 | 3.83M |
Jan 6 - Jan 7
| |||
Form 4
| -0.90% | -35.50K |
$19.71 | -$699,721.20 | 3.91M |
Jan 2 - Jan 3
| |||
Form 4
| -0.36% | -14.32K |
$23.96 | -$343,258.90 | 3.94M |
Dec 31
| |||
Form 4
|
∞
| 3.95M |
$16.00 |
—
| 3.95M |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMPEL NEUROPHARMA INC (IMPL) Snapshot price: $0.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.76M |
$15.00 |
—
| 2.76M |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||